![Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer - Mayanagi - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer - Mayanagi - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/64811f34-1de4-4284-97d5-64c51a6d122a/ags312243-fig-0001-m.jpg)
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer - Mayanagi - 2019 - Annals of Gastroenterological Surgery - Wiley Online Library
![Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/0dc498d9-544b-436f-9e9f-84734db7109b/gr2_lrg.jpg)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology
![Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India - ecancer Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India - ecancer](https://ecancer.org/en/journal/article/site/data/images/article/1296/can-15-1291fig1.gif)
Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India - ecancer
![Bennouna Jaafar on Twitter: "From the CROSS trial to CheckMate 577. Need to have OS data in CM577. longer follow-up. And come back more precisely to CPS-PD-L1 data. https://t.co/aUy1dDuxQ1" / Twitter Bennouna Jaafar on Twitter: "From the CROSS trial to CheckMate 577. Need to have OS data in CM577. longer follow-up. And come back more precisely to CPS-PD-L1 data. https://t.co/aUy1dDuxQ1" / Twitter](https://pbs.twimg.com/media/Ex9qAdbWgAQe4-Y.jpg)
Bennouna Jaafar on Twitter: "From the CROSS trial to CheckMate 577. Need to have OS data in CM577. longer follow-up. And come back more precisely to CPS-PD-L1 data. https://t.co/aUy1dDuxQ1" / Twitter
![Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/2113983482/2084460251/gr1.gif)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial - The Lancet Oncology
![Chemotherapy in gastric cancer & esophageal cancer - Basis, MAGIC trial, FLOT trial, CROSS protocol - YouTube Chemotherapy in gastric cancer & esophageal cancer - Basis, MAGIC trial, FLOT trial, CROSS protocol - YouTube](https://i.ytimg.com/vi/eRKZXflmnnw/maxresdefault.jpg)
Chemotherapy in gastric cancer & esophageal cancer - Basis, MAGIC trial, FLOT trial, CROSS protocol - YouTube
![Frontiers | Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial Frontiers | Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial](https://www.frontiersin.org/files/Articles/917961/fonc-12-917961-HTML/image_m/fonc-12-917961-g001.jpg)
Frontiers | Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
![Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | SpringerLink Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00066-020-01594-z/MediaObjects/66_2020_1594_Fig1_HTML.png)
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | SpringerLink
![Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-020-6669-y/MediaObjects/12885_2020_6669_Fig1_HTML.png)
Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study | BMC Cancer | Full Text
![IJERPH | Free Full-Text | Fostering Holistic Development with a Designed Multisport Intervention in Physical Education: A Class-Randomized Cross-Over Trial IJERPH | Free Full-Text | Fostering Holistic Development with a Designed Multisport Intervention in Physical Education: A Class-Randomized Cross-Over Trial](https://www.mdpi.com/ijerph/ijerph-18-09871/article_deploy/html/images/ijerph-18-09871-g001.png)
IJERPH | Free Full-Text | Fostering Holistic Development with a Designed Multisport Intervention in Physical Education: A Class-Randomized Cross-Over Trial
![CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9 - YouTube CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9 - YouTube](https://i.ytimg.com/vi/ukYqE1Tal7U/hqdefault.jpg)
CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9 - YouTube
![Moto elettriche da fuoristrada: modelli offroad e novità 2017 cross, enduro, trial, motard, rally, motoalpinismo... - Motociclismo Fuoristrada Moto elettriche da fuoristrada: modelli offroad e novità 2017 cross, enduro, trial, motard, rally, motoalpinismo... - Motociclismo Fuoristrada](https://www.motociclismofuoristrada.it/files/galleries/1/5/3/15397/B_25e11e11d533d9d6ebd4c8f6916ae626.jpg)
Moto elettriche da fuoristrada: modelli offroad e novità 2017 cross, enduro, trial, motard, rally, motoalpinismo... - Motociclismo Fuoristrada
![CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in ... CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in ...](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-018-4770-2/MediaObjects/12885_2018_4770_Fig1_HTML.png)
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in ...
![Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma | SpringerLink Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11605-020-04704-5/MediaObjects/11605_2020_4704_Fig1_HTML.png)
Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma | SpringerLink
![ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) | BMC Cancer | Full Text ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-017-3386-2/MediaObjects/12885_2017_3386_Fig1_HTML.gif)
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) | BMC Cancer | Full Text
![Moto elettriche da fuoristrada: modelli offroad e novità 2017 cross, enduro, trial, motard, rally, motoalpinismo... - Motociclismo Fuoristrada Moto elettriche da fuoristrada: modelli offroad e novità 2017 cross, enduro, trial, motard, rally, motoalpinismo... - Motociclismo Fuoristrada](https://www.motociclismofuoristrada.it/files/galleries/1/5/3/15397/B_1f92c8a3a4f2f3383dda869766b5aea4.jpg)